The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Overview of medically important antifungal azole derivatives
Open accessAbstract
Fungal infections are a major burden to the health and welfare of modern humans. They range from simply cosmetic, non-life-threatening skin infections to severe, systemic infections that may lead to significant debilitation or death. The selection of chemotherapeutic agents useful for the treatment of fungal infections is small. In this overview, a major chemical group with antifungal activity, the azole derivatives, is examined. Included are historical and state of the art information on the in vitro activity, experimental in vivo activity, mode of action, pharmacokinetics, clinical studies, and uses and adverse reactions of imidazoles currently marketed (clotrimazole, miconazole, econazole, ketoconazole, bifonazole, butoconazole, croconazole, fenticonazole, isoconazole, oxiconazole, sulconazole, and tioconazole) and under development (aliconazole and omoconazole), as well as triazoles currently marketed (terconazole) and under development (fluconazole, itraconazole, vibunazole, alteconazole, and ICI 195,739).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent Trends in the Discovery, Development, and Evaluation of Antifungal Agents
Fromtling, R. A., Braun, P. C., & Hector, R. (1987) · DigitalCommons - Fairfield (Fairfield University) · Cited by 474
Self-citationKetoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.
Loose, D. S., Kan, P. B., Hirst, M. A., Marcus, R. A., & Feldman, D. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110903 · Cited by 443
Ketoconazole Blocks Adrenal Steroid Synthesis
PONT, A., WILLIAMS, P. L., LOOSE, D. S., FELDMAN, D., REITZ, R. E., BOCHRA, C., & STEVENS, D. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-370 · Cited by 422
The use of ketoconazole as an inhibitor of steroid production
Oates, J. A., Wood, A. J. J., & Sonino, N. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171307 · Cited by 395
Hepatic Injury Associated With Ketoconazole Therapy
Lewis, J. H., Zimmerman, H. J., Benson, G. D., & Ishak, K. G. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80021-9 · Cited by 394
Humphrey, M. J., Jevons, S., & Tarbit, M. H. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.5.648 · Cited by 365
Heeres, J., Backx, L. J. J., Mostmans, J. H., & Van Cutsem, J. (1979) · Journal of Medicinal Chemistry · doi:10.1021/jm00194a023 · Cited by 343
Yersinia enterocolitica, a Primary Model for Bacterial Invasiveness
Cornelis, G., Laroche, Y., Balligand, G., Sory, M. P., & Wauters, G. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.1.64 · Cited by 322
Biochemical Targets for Antifungal Azole Derivatives: Hypothesis on the Mode of Action
Vanden Bossche, H. (1985) · Current Topics in Medical Mycology · doi:10.1007/978-1-4613-9547-8_12 · Cited by 321
Ketoconazole: A Review of its Therapeutic Efficacy in Superficial and Systemic Fungal Infections
Heel, R. C., Brogden, R. N., Carmine, A., Morley, P. A., Speight, T. M., & Avery, G. S. (1982) · Drugs · doi:10.2165/00003495-198223010-00001 · Cited by 276
Preparation and antimycotic properties of derivatives of 1-phenethylimidazole
Godefroi, E. F., Heeres, J., Van Cutsem, J., & Janssen, P. A. J. (1969) · Journal of Medicinal Chemistry · doi:10.1021/jm00305a014 · Cited by 267
Miconazole, a Broad-Spectrum Antimycotic Agent with Antibacterial Activity
Van Cutsem, J. M., & Thienpont, D. (1972) · Chemotherapy · doi:10.1159/000220875 · Cited by 263
Site of Action of Low Dose Ketoconazole on Androgen Biosynthesis in Men*
SANTEN, R. J., VAN DEN BOSSCHE, H., SYMOENS, J., BRUGMANS, J., & DECOSTER, R. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-4-732 · Cited by 231
Recurrent Vulvovaginal Candidiasis
Sobel, J. D. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152305 · Cited by 217
Ketoconazole and Other Imidazole Derivatives as Inhibitors of Steroidogenesis
FELDMAN, D. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-409 · Cited by 217
Disposition of ketoconazole, an oral antifungal, in humans
Brass, C., Galgiani, J. N., Blaschke, T. F., Defelice, R., O'Reilly, R. A., & Stevens, D. A. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.1.151 · Cited by 210
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis
Savani, D. V., Perfect, J. R., Cobo, L. M., & Durack, D. T. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.1.6 · Cited by 202
DISMUKES, W. E., STAMM, A. M., GRAYBILL, J. R., CRAVEN, P. C., STEVENS, D. A., STILLER, R. L., SAROSI, G. A., MEDOFF, G., GREGG, C. R., GALLIS, H. A., et al. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-1-13 · Cited by 189
Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo
Rogers, T. E., & Galgiani, J. N. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.3.418 · Cited by 184
Perfect, J. R., Savani, D. V., & Durack, D. T. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.4.579 · Cited by 184
Azole resistance in Candida albicans
Ryley, J. F., Wilson, R. G., & Barrett-Bee, K. J. (1984) · Medical Mycology · doi:10.1080/00362178485380091 · Cited by 182
The Effect of Ketoconazole on Amphotericin B in a Model of Disseminated Aspergillosis
Schaffner, A., & Frick, P. G. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.5.902 · Cited by 175
Hepatic reactions associated with ketoconazole in the United Kingdom.
Lake-Bakaar, G., Scheuer, P. J., & Sherlock, S. (1987) · BMJ · doi:10.1136/bmj.294.6569.419 · Cited by 171
Aspergillosis and other systemic mycoses. The growing problem
Fraser, D. W. (1979) · JAMA · doi:10.1001/jama.242.15.1631 · Cited by 167
Richardson, K., Brammer, K. W., Marriott, M. S., & Troke, P. F. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.832 · Cited by 166
A Clinical Trial of Itraconazole in the Treatment of Deep Mycoses and Leishmaniasis
Borelli, D. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s57 · Cited by 160
Gynecomastia with Ketoconazole
DeFelice, R., Johnson, D. G., & Galgiani, J. N. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.6.1073 · Cited by 159
Itraconazole, a new triazole that is orally active in aspergillosis
Van Cutsem, J., Van Gerven, F., Van de Ven, M. A., Borgers, M., & Janssen, P. A. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.4.527 · Cited by 158
Hepatic reactions during ketoconazole treatment
Janssen, P. A. J., & Symoens, J. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90519-3 · Cited by 157
KETOCONAZOLE, CYCLOSPORIN METABOLISM, AND RENAL TRANSPLANTATION
Ferguson, R., Sutherland, D. R., Simmons, R. L., & Najarian, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90851-0 · Cited by 155
Comparison of the in Vitro Antifungal Activities of Miconazole and a New Imidazole, R41,400
Dixon, D., Shadomy, S., Shadomy, H. J., Espinel‐Ingroff, A., & Kerkering, T. M. (1978) · The Journal of Infectious Diseases · doi:10.1093/infdis/138.2.245 · Cited by 149
Biochemical effects of miconazole on fungi—I
den Bossche, H. V. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90220-2 · Cited by 148
Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones
Heeres, J., Backx, L. J. J., & Van Cutsem, J. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00373a015 · Cited by 143
Ketoconazole Therapy in Advanced Prostatic Cancer
Trachtenberg, J. (1984) · The Journal of Urology · doi:10.1016/s0022-5347(17)49464-x · Cited by 137
In vitro studies with R 51,211 (itraconazole)
Espinel-Ingroff, A. V., Shadomy, S., & Gebhart, R. J. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.1.5 · Cited by 129
Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers
Huang, Y. C., Colaizzi, J. L., Bierman, R. H., Woestenborghs, R., & Heykants, J. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.2.206 · Cited by 123
Heterogeneity of action of mechanisms among antimycotic imidazoles
Sud, I. J., & FEINGOLD, D. S. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.20.1.71 · Cited by 122
Dupont, B., & Drouhet, E. (1988) · Medical Mycology · doi:10.1080/02681218880000081 · Cited by 122
Determination of cisapride in plasma and animal tissues by high-performance liquid chromatography
Woestenborghs, R. J. H., Lorreyne, W., Rompaey, F. V., & Heykants, J. (1988) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)81094-4 · Cited by 120
Combination Therapy of Experimental Candidiasis, Cryptococcosis and Aspergillosis in Mice
Polak, A., Scholer, H. J., & Wall, M. (2009) · Chemotherapy · doi:10.1159/000238138 · Cited by 118
Heel, R. C., Brogden, R. N., Pakes, G. E., Speight, T. M., & Avery, G. S. (1980) · Drugs · doi:10.2165/00003495-198019010-00002 · Cited by 117
Mechanisms of Action of the Antimycotic Imidazoles
Sud, I. J., & Feingold, D. S. (1981) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12521036 · Cited by 117
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits
Perfect, J. R., & Durack, D. T. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.1.81 · Cited by 107
Dupont, B., & Drouhet, E. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s71 · Cited by 104
Influence of food on the pharmacokinetics of ketoconazole
Daneshmend, T. K., Warnock, D. W., Ene, M., Johnson, E. M., Potten, M. R., Richardson, M. D., & Williamson, P. J. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.1.1 · Cited by 99
Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans
Georgopapadakou, N. H., Dix, B. A., SMITH, S. A., Freudenberger, J. S., & Funke, P. T. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.1.46 · Cited by 99
Deep Infections From Petriellidium boydii Treated With Miconazole
Lutwick, L. I. (1979) · JAMA · doi:10.1001/jama.1979.03290290040023 · Cited by 99
Cytochemical and Biochemical Studies of Yeasts After In Vitro Exposure to Miconazole
Nollin, S. D., Belle, H. V., Goossens, F. M., Thoné, F., & Borgers, M. J. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.3.500 · Cited by 97
Ketoconazole — a new broad spectrum orally active antimycotic
Thienpont, D., Cutsem, J. V., Gerven, F. V., Heeres, J., & Janssen, P. A. J. (1979) · Cellular and Molecular Life Sciences · doi:10.1007/bf01960348 · Cited by 96
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice
Troke, P. F., Andrews, R. J., Brammer, K. W., Marriott, M. S., & Richardson, K. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.6.815 · Cited by 94
Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjects.
Brugmans, J. P., Thienpont, D., van Wijngaarden, I., et al. (1971) · PubMed · Cited by 93
Odds, F. C. (1980) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/6.6.749 · Cited by 90
Primary site of action of ketoconazole on Candida albicans
Uno, J., Shigematsu, M. L., & Arai, T. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.6.912 · Cited by 89
Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro
Odds, F. C., Cheesman, S. L., & Abbott, A. B. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.4.473 · Cited by 89
Green, C. A., Farr, P. M., & Shuster, S. (1987) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1987.tb05815.x · Cited by 89
Effect of ketoconazole and other imidazole fungicides on testosterone biosynthesis
Schürmeyer, T., & Nieschlag, E. (1984) · European Journal of Endocrinology · doi:10.1530/acta.0.1050275 · Cited by 88
Fatal Hepatitis Associated With Ketoconazole Therapy
Duarte, P. A., Chow, C. C., Simmons, F., & Ruskin, J. N. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350170237037 · Cited by 87
The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole
Odds, F. C., Milne, L. J. R., Gentles, J. C., & Ball, E. H. (1980) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/6.1.97 · Cited by 86
In vitro and in vivo Drug Studies with Three Agents of Central Nervous System Phaeohyphomycosis
Dixon, D. M., & Polak, A. (2009) · Chemotherapy · doi:10.1159/000238485 · Cited by 85
Ganer, A., Arathoon, E., & Stevens, D. A. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s77 · Cited by 84
Odds, F. C., Webster, C. E., & Abbott, A. B. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.2.105 · Cited by 81
Dieperink, H. H., & Møller, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91231-4 · Cited by 80
Laboratory assessment of the antimycotic drug clotrimazole
Holt, R., & Newman, R. L. (1972) · Journal of Clinical Pathology · doi:10.1136/jcp.25.12.1089 · Cited by 76
Shepp, D. H., Klosterman, A. M., Siegel, M. S., & Meyers, J. D. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/152.6.1257 · Cited by 76
In Vitro Antifungal Activity of Clotrimazole (Bay b 5097)
Shadomy, S. (1971) · Infection and Immunity · doi:10.1128/iai.4.2.143-148.1971 · Cited by 72
Ketoconazole Prevents Candida Sepsis in Critically Ill Surgical Patients
Slotman, G. J., & Burchard, K. W. (1987) · Archives of Surgery · doi:10.1001/archsurg.1987.01400140029002 · Cited by 72
Antimycotic efficacy of bifonazole in vitro and in vivo.
Plempel, M., Regel, E., & Kh, B. (1983) · PubMed · Cited by 70
Mechanism of Inhibition of Human Testicular Steroidogenesis by Oral Ketoconazole∗
Rajfer, J., Sikka, S. C., Rivera, F., & Handelsman, D. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-5-1193 · Cited by 69
Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients
Fainstein, V., Bodey, G. P., Elting, L. S., Maksymiuk, A. W., Keating, M. J., & McCredie, K. B. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.1.11 · Cited by 67
Baxter, J. G., Brass, C., Schentag, J. J., & Slaughter, R. L. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750504 · Cited by 67
ODDS, F. C., COCKAYNE, A., HAYWARD, J., & ABBOTT, A. B. (1985) · Microbiology · doi:10.1099/00221287-131-10-2581 · Cited by 67
Mode of Action of Miconazole on Candida albicans: Effect on Growth, Viability and K+ Release
COPE, J. E. (1980) · Microbiology · doi:10.1099/00221287-119-1-245 · Cited by 65
THE EFFECT OF KETOCONAZOLE ON STEROIDOGENESIS IN CULTURED MOUSE ADRENAL CORTEX TUMOR CELLS*
Kowal, J. (1983) · Endocrinology · doi:10.1210/endo-112-4-1541 · Cited by 64
Treatment of cryptococcal meningitis in mice with fluconazole
de Fernandez, E. P., Patiño, M. M., Graybill, J. R., & Tarbit, M. H. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.2.261 · Cited by 62
Ånséhn, S., & Nilsson, L. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.1.22 · Cited by 62
Degenerative Changes in Fungi After Itraconazole Treatment
Borgers, Μ., & de Ven, M.-A. A. V. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s33 · Cited by 60
Cryptococcal Meningitis and Fluconazole
Dupont, B., & DROUHET, E. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-778_2 · Cited by 59
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice
Troke, P. F., Andrews, R. J., Marriott, M. S., & Richardson, K. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/19.5.663 · Cited by 58
Itraconazole in the Treatment of Dermatophytoses: A Comparison of Two Daily Dosages
Degreef, H. J., Mariën, K., de Veylder, H., Duprez, K., Borghys, A. M., & Verhoeve, L. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s104 · Cited by 57
Shadomy, S., White, S. C., Yu, H. P., et al. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/152.6.1249 · Cited by 52
Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal
Heeres, J., Hendrickx, R., & Van Cutsem, J. (1983) · Journal of Medicinal Chemistry · doi:10.1021/jm00358a032 · Cited by 51
Induction potential of antifungals containing an imidazole or triazole moiety
Lavrjusen, K., Houdt, J. V., Thius, D., Meuldermans, W., & Heykants, J. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90305-9 · Cited by 50
Persistent adrenal insufficiency secondary to low-dose ketoconazole therapy
Best, T. R., Jenkins, J. K., Murphy, F. Y., Nicks, S. A., Bussell, K. L., & Vesely, D. L. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90123-9 · Cited by 50
Inhibition of cholesterol synthesis by ketoconazole
Kraemer, F. B., & Pont, A. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90816-8 · Cited by 50
Systemic mycoses in the United States, 1980–1982
Reingold, A. L., Lu, X. D., Plikaytis, B. D., & Ajello, L. (1986) · Medical Mycology · doi:10.1080/02681218680000691 · Cited by 50
Successful Treatment of Cryptococcal Meningitis With Intraventricular Miconazole
Graybill, J. R., & Levine, H. B. (1978) · Archives of Internal Medicine · doi:10.1001/archinte.138.5.814 · Cited by 47
Effect of ketoconazole on isolated mitochondria from Candida albicans
Shigematsu, M. L., Uno, J., & Arai, T. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.6.919 · Cited by 46
Wood, P. R., & Tarbit, M. H. (1986) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)83458-1 · Cited by 43
Odds, F. C., Abbott, A. B., Pye, G., & Troke, P. F. (1986) · Medical Mycology · doi:10.1080/02681218680000461 · Cited by 42
Inhibition of sterol C14 demethylation by imidazole-containing antifungals
Pye, G. W., & Marriott, M. S. (1982) · Medical Mycology · doi:10.1080/00362178285380461 · Cited by 42
Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical use
Lefler, E., & Stevens, D. A. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.4.450 · Cited by 42
Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858)
Graybill, J. R., Sun, S. H., & Ahrens, J. (1986) · Medical Mycology · doi:10.1080/02681218680000171 · Cited by 41
Morita, T., & Nozawa, Y. (1985) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12277141 · Cited by 39
Kobayashi, G. S., Travis, S. J., & Medoff, G. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.4.660 · Cited by 39
Hernanz, A. D. P., Delgado‐Vicente, S., Ramos, F., & Belaustegui, A. R.-N. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s121 · Cited by 39
Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo.
Polak, A. (1982) · PubMed · Cited by 39
Action of fluconazole (UK-49, 858) in relation to other systemic antifungal azoles
Hughes, C. E., & Beggs, W. H. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/19.2.171 · Cited by 38
Itraconazole treatment of murine aspergillosis
Graybill, J. R., & Ahrens, J. (1985) · Medical Mycology · doi:10.1080/00362178585380321 · Cited by 38
Miconazole in Cryptococcosis and Systemic Candidiasis: A Word of Caution
Bennett, J. E., & Remington, J. S. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-5-708 · Cited by 37
Corrado, M. L., Kramer, M., CUMMINGS, M. C., & Eng, R. H. K. (1982) · Medical Mycology · doi:10.1080/00362178285380181 · Cited by 37
Bastide, M., Jouvert, S., & Bastide, J.-M. (1982) · Canadian Journal of Microbiology · doi:10.1139/m82-166 · Cited by 36
Cauwenbergh, G. F. M. J., & Doncker, P. D. (1986) · Drug Development Research · doi:10.1002/ddr.430080136 · Cited by 35
Treatment of Chronic Dermatophytosis and Chronic Oral Candidosis with Itraconazole
Hay, R. J., & CLAYTON, Y. M. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s114 · Cited by 33
Taylor, F. R., Rodriguez, R. J., & Parks, L. W. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.4.515 · Cited by 31
Treatment of Experimental Murine Aspergillosis with BAY n7133
Graybill, J. R., Kaster, S. R., & Drutz, D. J. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/148.5.898 · Cited by 29
Comparison of itraconazole and ketoconazole in the treatment of experimental candidal vaginitis
Sobel, J. D., & Muller, G. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.2.266 · Cited by 28
Itraconazole in Pityriasis Versicolor
Estrada, R. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s128 · Cited by 28
Ketoconazole in the Treatment of Coccidioidomycosis
Galgiani, J. N. (1983) · Drugs · doi:10.2165/00003495-198326040-00005 · Cited by 27
Galimberti, R., Villalba, I. L., Galarza, S., Raimondi, A., & Flores, V. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s134 · Cited by 25
Comparison of miconazole– and ketoconazole–induced release of K+ from Candida species
Beggs, W. H. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/11.4.381 · Cited by 22
Calderón-Márquez, J. J. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s143 · Cited by 22
Chemotherapy for the Systemic Mycoses: The Prelude to Ketoconazole
Utz, J. P. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.4.625 · Cited by 22
A comparison of bifonazole (bay h 4502) with clotrimazolein vitro
Shadomy, S., Dixon, D. M., & May, R. (1982) · Medical Mycology · doi:10.1080/00362178285380451 · Cited by 21
Stenderup, A., & Schønheyder, H. C. (1984) · PubMed · Cited by 21
Cryptococcus neoformans: Comparisons of in vitro antifungal susceptibilities of serotypes AD and BC
Fromtling, R. A., Abruzzo, G. K., & Bulmer, G. S. (1986) · Mycopathologia · doi:10.1007/bf00437258 · Cited by 20
Self-citationLyman, C. A., Sugar, A. M., & Diamond, R. D. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.1.161 · Cited by 20
Beggs, W. H. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.5.699 · Cited by 19
Sodium and Hypertension Still a Controversy in 1986
Francischetti, E. A., Fagundes, V. G. D. A., & Oigman, W. (1986) · Drugs · doi:10.2165/00003495-198600314-00005 · Cited by 18
Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole
Hoeprich, P. D., & Merry, J. M. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.24.2.269-271.1986 · Cited by 18
Brown, D., Mr, H., Me, L., et al. (1986) · PubMed · Cited by 18
Therapeutic Efficacy of Itraconazole in Systemic Candidosis in Guinea Pigs
Cutsem, J. V., Fransen, J., & Janssen, P. A. J. (2009) · Chemotherapy · doi:10.1159/000238475 · Cited by 17
The effects of ketoconzole on cellular and humoral immune functions
van Rensburg, C. E. J., Anderson, R., Joone, G., van der Merve, M. F., & Eftychis, H. A. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/11.1.49 · Cited by 17
Failure of Ketoconazole in an Immunosuppressed Patient with Pulmonary Blastomycosis
Greene, N. B., Baughman, R. P., Kim, C. K., & Roselle, G. A. (1985) · CHEST Journal · doi:10.1378/chest.88.4.640 · Cited by 17
Alford, R. H., & Cartwright, B. B. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.4.575 · Cited by 16
Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents
Odds, F. C., Cheesman, S. L., & Abbott, A. B. (1985) · Medical Mycology · doi:10.1080/00362178585380611 · Cited by 15
Beggs, W. H. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.3.397 · Cited by 15
Fierlafijn, E. (1971) · JAMA · doi:10.1001/jama.1971.03190200081030 · Cited by 14
Scott, E. M., Gorman, S. P., Millership, J. S., et al. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/17.4.423 · Cited by 13
Itraconazole treatment of experimental systemic candidiasis in male rats
Yozwiak, M. L., & Galgiani, J. N. (1987) · Medical Mycology · doi:10.1080/02681218780000171 · Cited by 12
Treatment of systemic mycoses with ketoconazole: studies of ketoconazole serum levels.
Shadomy, S., Espinel-Ingroff, A. V., Tartaglione, T. A., & We, D. (1986) · PubMed · Cited by 9
Benijts, G., Vignalli, M., Kreysing, W., et al. (1980) · Current Medical Research and Opinion · doi:10.1185/03007998009116516 · Cited by 8
Rapid fungicidal action of tioconazole and miconazole
Beggs, W. H. (1987) · Mycopathologia · doi:10.1007/bf00437242 · Cited by 5
Beggs, W. H., & Hughes, C. E. (1986) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(86)90061-1 · Cited by 4
Cited by
Current and emerging azole antifungal agents
Sheehan, D. J., Hitchcock, C. A., & Sibley, C. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.40 · Cited by 1,137
The biology and chemistry of antifungal agents: A review
Kathiravan, M. K., Salake, A. B., Chothe, A. S., Dudhe, P. B., Watode, R. P., Mukta, M. S., & Gadhwe, S. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.04.045 · Cited by 664
Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast
Parsons, A. B., Lopez, A., Givoni, I. E., Williams, D. E., Gray, C. A., Porter, J., Chua, G., Sopko, R., Brost, R. L., Ho, C.-H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.040 · Cited by 515
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2012) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 505
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 498
Metadata
- Authors
- Fromtling, R. A.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1988-04
- Volume
- 1
- Issue
- 2
- Pages
- 187-217
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W1956991203
- Cited by
- 398
- References
- 133
- FWCI
- 12.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.